FDA Approves TOFIDENCE™ (tocilizumab-bavi) a Biosimilar of ACTEMRA® developed by Bio-Thera Solutions

TOFIDENCE is Bio-Thera’s first product approved by USFDA. TOFIDENCE is the first monoclonal antibody drug researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States TOFIDENCE is the first biosimilar to Actemra approved by USFDA…